| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $99.6M | — | -6.5% |
| Cost of Revenue | $38.3M | — | -0.4% |
| R&D Expense | $65.6M | — | +8.0% |
| SG&A Expense | $65.1M | — | +2.6% |
| Operating Income | -$69.4M | — | -23.2% |
| Pre-tax Income | -$49.6M | — | -2.3% |
| Income Tax | $1.4M | — | — |
| Net Income | -$51.0M | — | -5.3% |
| EPS (Basic) | -$0.05 | — | -25.0% |
| EPS (Diluted) | -$0.05 | — | -25.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $651.3M | -4.2% | -14.0% |
| Short-term Investments | $10.0M | +0.0% | — |
| Accounts Receivable | $54.1M | -49.0% | -29.4% |
| Inventory | $86.0M | +15.0% | +62.0% |
| Current Assets | $944.7M | -7.3% | -9.3% |
| Total Assets | $1.10B | -6.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.9M | — | +80.7% |
| Capital Expenditures | $1.2M | — | -22.1% |
| Investing Cash Flow | -$22.3M | — | -106.8% |
| Financing Cash Flow | $5.6M | — | -87.1% |
| Free Cash Flow | -$13.1M | — | +79.3% |
| -6.6% |
| Current Liabilities | $393.0M | -5.6% | +22.9% |
| Total Liabilities | $433.8M | -5.1% | +19.6% |
| Stockholders' Equity | $662.0M | -7.5% | -18.3% |